Nelson K Y Wong

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Prostate Cancer

Radical Prostatectomy

Top Venues

Molecular cancer research : MCR

Cancer research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Nelson K Y Wong, Xin Dong, Yen-Yi Lin, Hui Xue, Rebecca Wu, Dong Lin, Colin Collins, Yuzhuo Z Wang
Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer. Cells 11 (9) (2022)
Xin Dong, Hui Xue, Fan Mo, Yen-Yi Lin, Dong Lin, Nelson K Y Wong, Yingqiang Sun, Scott Wilkinson, Anson T Ku, Jun Hao, Xinpei Ci, Rebecca Wu, Anne Haegert, Rebecca Silver, Mary-Ellen Taplin, Steven P Balk, Joshi J Alumkal, Adam G Sowalsky, Martin Gleave, Colin Collins, Yuzhuo Z Wang
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications. Molecular cancer research : MCR 20 (5) (2022)
Marta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, Nelson K Y Wong, Shang Li, G Bea A Wisman, Aleksandra Hamilton, Joshua Hoenisch, Amy Dawson, Cheng-Han Lee, Madison Bittner, Hannah Kim, Gabriel E DiMattia, Christianne A R Lok, Cor Lieftink, Roderick L Beijersbergen, Steven de Jong, Mark S Carey, René Bernards, Katrien Berns
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition. Molecular cancer therapeutics 21 (12) (2022)
Raunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, Stanislav Volik, Yen-Yi Lin, Shawn Anderson, Hannah Kim, Anne M Haegert, Shane Colborne, Nelson K Y Wong, Brian McConeghy, Robert H Bell, Sonal Brahmbhatt, Cheng-Han Lee, Gabriel E DiMattia, Stephane Le Bihan, Gregg B Morin, Colin C Collins, Mark S Carey
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability. Cancer research 81 (7) (2021)